Data from Resonate- 2 Study Highlights  Ibrutinib Performance in 11q deletion disorder

Data from Resonate- 2 Study Highlights Ibrutinib Performance in 11q deletion disorder

User Photo
ASHReport

4 years
844 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Barr, MD of University of Rochester, discusses data from the Resonate-2 Study at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>